These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6384986)

  • 1. Bone marrow transplantation.
    Clink H
    Practitioner; 1984 Oct; 228(1396):899-901. PubMed ID: 6384986
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral manifestations and management of graft-versus-host disease].
    Yang ZP
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1987 Jan; 22(1):27-30, 63. PubMed ID: 3304863
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic bone marrow transplant in acute leukemias and chronic myeloid leukemia. Preliminary results from the BMT center of Pesaro.
    Izzi T; Polchi P; Galimberti M; Delfini C; Moretti L; Manna A; Porcellini A; Lucarelli G; Di Pietrantonj F
    Haematologica; 1984; 69(2):194-210. PubMed ID: 6429005
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transplantation of bone marrow].
    Stefanović S
    Bilt Hematol Transfuz; 1983; 11(2-3):3-11. PubMed ID: 6391466
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of cyclosporin A in 5 leukemia patients receiving allogeneic bone marrow transplantation].
    Akao Y; Sao H; Tahara T; Yoshikawa H; Yoshikawa S; Morishima Y; Hiraiwa A; Naoe T
    Rinsho Ketsueki; 1984 Sep; 25(9):1417-26. PubMed ID: 6394783
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bone marrow transplantation in children].
    Radwańska U
    Pediatr Pol; 1995 Nov; 70(11):899-905. PubMed ID: 8677153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular manifestations in bone marrow transplantation.
    Spires R
    J Ophthalmic Nurs Technol; 1993; 12(5):208-10. PubMed ID: 8301680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow infarction due to acute graft-versus-host disease in an acute lymphoblastic leukemia patient after unrelated bone marrow transplantation.
    Mori A; Hashino S; Imamura M; Kahata K; Kawakami H; Shibata M; Kobayashi S; Tanaka J; Asaka M
    Bone Marrow Transplant; 1998 Mar; 21(6):615-7. PubMed ID: 9543066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laryngeal stenosis associated with chronic graft-versus-host disease following unrelated bone marrow transplantation.
    Hirokawa M; Kume M; Wu T; Ishikawa K; Sawada KI
    Bone Marrow Transplant; 2006 Sep; 38(5):387-8. PubMed ID: 16862163
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
    Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic peripheral blood versus bone marrow transplantation: children are small adults and more.
    Wall DA
    J Clin Oncol; 2004 Dec; 22(24):4865-6. PubMed ID: 15520051
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow transplantation.
    Nuscher R; Baltzer L; Repinec DA; Almquist G; Barrett JE; LaBombardi S; DeMao JD; Diver ME; Field BA; Lee MC
    Am J Nurs; 1984 Jun; 84(6):764-72. PubMed ID: 6375375
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppression, graft-versus-host disease, and infection after bone marrow transplantation.
    Kramer BS; Elfenbein GJ
    J Fla Med Assoc; 1984 May; 71(5):321-8. PubMed ID: 6429272
    [No Abstract]   [Full Text] [Related]  

  • 15. Statistical analysis of favorable prognostic factors in allogeneic bone marrow transplantation for acute leukemia in Japan.
    Inoue T; Masaoka T; Mori T; Katoh S; Saito Y; Harada M; Saito M; Moriyama Y; Ohira M; Morita K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():563-71. PubMed ID: 6394817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation in the treatment of leukemia.
    Grossbard EB; O'Reilly RJ
    Clin Bull; 1980; 10(3):109-13. PubMed ID: 7004663
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological complications of bone marrow transplantation in childhood.
    Wiznitzer M; Packer RJ; August CS; Burkey ED
    Ann Neurol; 1984 Nov; 16(5):569-76. PubMed ID: 6391364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Marrow transplantation in leukemia-recent trends].
    Gratwohl A; Signer E
    Monatsschr Kinderheilkd; 1982 Nov; 130(11):810-3. PubMed ID: 6759923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute graft-versus-host disease in allogeneic bone marrow transplantation].
    Harada M; Funada H; Yoshida T; Kodo H; Mori T; Matsue K; Shiobara S; Ohtake S; Odaka K; Teshima H
    Rinsho Ketsueki; 1984 Jul; 25(7):1043-51. PubMed ID: 6389930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.